Subtype
Uveal Melanoma
CI-CAN-00001637UVMExplore in graph →
59 active trials1 approved drugs17 evidence items
- NCIt
- C7712
- OncoTree
- UM
- DOID
- 6039
- UMLS CUI
- C0220633
- MeSH
- D000098943
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001637UVMExplore in graph →
Rankings
11 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.
| Metric | Scope | Rank / eligible | Δ | Value | Percentile | Confidence | Formula | Generated | Inputs |
|---|---|---|---|---|---|---|---|---|---|
| Curated clinical evidence items | World · both sexes · all ages · latest · all malignant entities | #159 / 492 | = | 17 count | 67.8 | Medium confidence | ci-civic-evidence-v1 | Sep 30, 2026 | showformula: COUNT(civic_evidence_items) WHERE status = ACCEPTED AND cancer_id IN descendants(cancer)
inputs hash 00ec4259c26ee135c931f5a6 Trace lineage (admin) |
| Genes with curated or cohort evidence | World · both sexes · all ages · latest · all malignant entities | #158 / 521 | = | 103 count | 69.8 | Medium confidence | ci-genes-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT gene) FROM (civic accepted evidence ∪ gdc frequency ≥ 0.05 AND cases_affected ≥ 20)
inputs hash dc02edfbbd5b601934401df4 Trace lineage (admin) |
| Public genomic cohorts | World · both sexes · all ages · latest · all malignant entities | #149 / 296 | = | 5 count | 49.8 | Medium confidence | ci-cohorts-v1 | Sep 30, 2026 | showformula: COUNT(genomic_cohorts) WHERE cancer_id IN descendants(cancer)
inputs hash 401b2e31f9813fbae9c90ab7 Trace lineage (admin) |
| Publications, last 12 months | World · both sexes · all ages · latest · all malignant entities | #228 / 2,294 | = | 207 count | 90.1 | Medium confidence | ci-pubs-12m-v1 | Sep 30, 2026 | showformula: literature_counts.count WHERE window_key = 12m
inputs hash b1963bee32e72b8b6e51efec Trace lineage (admin) |
| Publications, last 5 years | World · both sexes · all ages · latest · all malignant entities | #219 / 2,873 | = | 1,244 count | 92.4 | Medium confidence | ci-pubs-5y-v1 | Sep 30, 2026 | showformula: literature_counts.count WHERE window_key = 5y (query stored per row)
inputs hash 7b01855837dd178dff17a0c3 Trace lineage (admin) |
| Active clinical trials | World · both sexes · all ages · latest · all malignant entities | #260 / 1,654 | = | 59 count | 84.3 | Medium confidence | ci-active-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING)
inputs hash d8f333d5bfdbadb41c05f9e2 Trace lineage (admin) |
| Active Phase III trials | World · both sexes · all ages · latest · all malignant entities | #204 / 810 | = | 9 count | 74.9 | Medium confidence | ci-phase3-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) … active statuses AND PHASE3 = ANY(phases)
inputs hash 55bad1a93f2cbb5682249863 Trace lineage (admin) |
| Recruiting clinical trials | World · both sexes · all ages · latest · all malignant entities | #274 / 1,284 | = | 29 count | 78.7 | Medium confidence | ci-recruiting-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL
inputs hash 00002505dcded3e0217a182d Trace lineage (admin) |
| Recruiting Phase III trials | World · both sexes · all ages · latest · all malignant entities | #180 / 585 | = | 6 count | 69.3 | High confidence | ci-phase3-recruiting-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND PHASE3 = ANY(phases) AND study_type = INTERVENTIONAL
inputs hash 3f7191c10405ddd12eec0cad Trace lineage (admin) |
| Sponsor concentration (HHI) | World · both sexes · all ages · latest · all malignant entities | #401 / 614 | = | 0.034 index (0–1) | 34.7 | High confidence | ci-sponsor-hhi-v1 | Sep 30, 2026 | showformula: Σ (active_trials_by_lead_sponsor / active_trials)² over the cancer and its descendants
|
| Trial termination share | World · both sexes · all ages · latest · all malignant entities | #261 / 454 | = | 0.33 ratio | 42.6 | Medium confidence | ci-trial-termination-v1 | Sep 30, 2026 | showformula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL
|
Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.
"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.
inputs hash 909c6c96975dbbd1461c83c4
inputs hash aebac3d92951539ea771c6d9
Unmet need · computed
No research-gap components for this entity